MYX.LSE MYCELX Technologies Corporation
- Market cap
- GBX 11.3M
- P/E
- 23.3x
- P/B
- 3.56x
- ROE
- -134.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is MYX.LSE undervalued?
Graham numberMYX.LSE trades 91.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
MYCELX Technologies Corporation fundamental analysis
No fundamental analysis for MYCELX Technologies Corporation yet.
MYCELX Technologies Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About MYCELX Technologies Corporation
MYCELX Technologies Corporation, a clean water technology company, provides water treatment solutions to the PFAS remediation and produced water markets in the Nigeria, Middle East, the United States, Australia, and internationally. The company sells and leases its equipment; and sells filtration media. It also provides clean water technology equipment and related services to the oil and gas, power, marine and heavy manufacturing sectors. The company was incorporated in 1994…
Full company profileMYCELX Technologies Corporation financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
MYCELX Technologies Corporation annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 7.92M | 13.8M | 27.0M | 11.9M | 7.10M | 8.48M | 10.0M | 10.9M | 4.90M | 11.7M | 8.43M |
| Gross Profit | 4.10M | 7.47M | 14.1M | 6.09M | 1.59M | 3.28M | 4.44M | 3.89M | 1.34M | 5.62M | 4.93M |
| Operating Income | -2.98M | -728K | 4.36M | -2.41M | -6.05M | -1.51M | -3.58M | -3.33M | -4.55M | 193K | -5.65M |
| EBITDA | -1.60M | 463K | 5.59M | -1.15M | -4.22M | 19.0K | -2.48M | -2.46M | -2.23M | 1.11M | -5.01M |
| Net Income | -3.28M | -1.16M | 3.07M | -2.96M | -6.09M | -1.43M | -3.99M | -3.71M | -2.72M | 334K | -5.74M |
| EPS | -0.17 | -0.06 | 0.15 | -0.15 | -0.31 | -0.07 | -0.18 | -0.16 | -0.12 | 0.01 | -0.24 |
| Balance Sheet | |||||||||||
| Total Assets | 22.4M | 21.5M | 27.9M | 24.5M | 19.1M | 15.7M | 13.6M | 10.4M | 10.0M | 8.67M | 8.77M |
| Total Liabilities | 3.52M | 3.68M | 6.97M | 4.66M | 5.34M | 3.04M | 2.79M | 3.23M | 4.79M | 3.01M | 4.52M |
| Shareholders' Equity | 18.8M | 17.8M | 21.0M | 19.8M | 13.8M | 12.6M | 10.8M | 7.16M | 5.26M | 5.66M | 4.25M |
| Cash & Short-term Investments | 5.14M | 5.17M | 4.87M | 3.65M | 3.29M | 3.13M | 1.65M | 383K | 1.26M | 812K | 499K |
| Total Debt | 2.01M | 1.92M | 1.83M | 2.51M | 3.09M | 1.47M | 1.22M | 889K | 1.26M | 1.26M | 1.12M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 105K | 194K | 298K | -1.92M | -1.50M | -3.43M | -2.69M | -1.12M | -2.15M | -863K | -1.28M |
| Capital Expenditure | 194K | 58.0K | 515K | 867K | 159K | 370K | 842K | 90.0K | 45.0K | 35.0K | 172K |
| Free Cash Flow | -89.0K | 136K | -217K | -2.79M | -1.66M | -3.80M | -3.53M | -1.21M | -2.20M | -898K | -1.45M |
| Ratios | |||||||||||
| ROE | -17.4% | -6.5% | 14.6% | -14.9% | -44.2% | -11.3% | -36.8% | -51.8% | -51.7% | 5.9% | -134.8% |
| ROA | -14.7% | -5.4% | 11.0% | -12.1% | -31.9% | -9.1% | -29.3% | -35.7% | -27.1% | 3.9% | -65.4% |
| Net Profit Margin | -41.4% | -8.4% | 11.4% | -24.8% | -85.8% | -16.8% | -39.8% | -34.0% | -55.5% | 2.8% | -68.0% |
| Debt to Equity | 0.11x | 0.11x | 0.09x | 0.13x | 0.22x | 0.12x | 0.11x | 0.12x | 0.24x | 0.22x | 0.26x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
MYCELX Technologies Corporation dividends
MYCELX Technologies Corporation has not paid dividends in the last 9 fiscal years.
Who owns MYCELX Technologies Corporation
- Insiders 20.13%
- Institutions 31.17%
- Public & others 48.70%
- Shares outstanding 24.4M
- Free float 12.9M
MYCELX Technologies Corporation company profile
- Company name
- MYCELX Technologies Corporation
- Ticker
- MYX.LSE
- Exchange
- London Exchange
- Sector
- Industrials
- Industry
- Machinery
- Fiscal year end
- December
- Address
- 1650 International Court, Norcross, GA, United States, 30093
- Phone
- 770 534 3118
- Website
- mycelx.com
About MYCELX Technologies Corporation
MYCELX Technologies Corporation, a clean water technology company, provides water treatment solutions to the PFAS remediation and produced water markets in the Nigeria, Middle East, the United States, Australia, and internationally. The company sells and leases its equipment; and sells filtration media. It also provides clean water technology equipment and related services to the oil and gas, power, marine and heavy manufacturing sectors. The company was incorporated in 1994 and is headquartered in Norcross, Georgia.
MYCELX Technologies Corporation management
6- Ms. Connie MixonCEO & Executive Director · born 1955
- Mr. Haluk AlperCo-Founder, President, Chief Science Officer & Executive Director · born 1957
- Mr. John Mansfield Sr.Co-Founder & Chairman Emeritus · born 1932
- Ms. Kimberly SlaytonCFO & Secretary
- Mr. Jim WeidlerExecutive Vice President of Business Development
- Matthew GoysichExecutive Vice President